Clot Management Devices Market Report: Trends, Forecast and Competitive Analysis to 2030

Clot Management Devices Trends and Forecast

The future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets. The global clot management devices market is expected to reach an estimated $2.5 billion by 2030 with a CAGR of 5.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.

A more than 150-page report is developed to help in your business decisions.

Clot Management Devices by Segment

The study includes a forecast for the global clot management devices by product, percutaneous thrombectomy devices type, end use, and region.

Clot Management Devices Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Neurovascular Embolectomy Devices
• Embolectomy Balloon Catheters
• Percutaneous Thrombectomy Devices
• Catheter-Directed Thrombolysis (CDT) Devices
• Inferior Vena Cava Filters (IVCF)

Clot Management Devices Market by Percutaneous Thrombectomy Devices Type [Shipment Analysis by Value from 2018 to 2030]:

• Aspiration Thrombectomy Devices
• Percutaneous Mechanical Thrombectomy Devices

Clot Management Devices Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Diagnostic Centers
• Hospitals
• Others

Clot Management Devices Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Clot Management Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies clot management devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the clot management devices companies profiled in this report include-

• Medtronic
• Boston Scientific Corporation
• iVascular SLU
• Teleflex
• Edwards Lifesciences Corporation
• LeMaitre Vascular
• Vascular Solutions
• Straub Medical
• Cook Medical
• DePuy Synthes

Clot Management Devices Market Insights

Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.

Within this market, hospitals will remain the largest segment due to increasing adoption of specialized departments, advanced labs, and operating rooms in hospitals for cardiovascular treatments.

APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.

Features of the Global Clot Management Devices Market

Market Size Estimates: Clot management devices market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Clot management devices market size by product, percutaneous thrombectomy devices type, end use, and region. in terms of value ($B).

Regional Analysis: Clot management devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, percutaneous thrombectomy devices types, end uses, and region.s for the clot management devices market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the clot management devices market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1. What is the clot management devices market size?

Answer: The global clot management devices market is expected to reach an estimated $2.5 billion by 2030.

Q.2. What is the growth forecast for clot management devices market?

Answer: The global clot management devices market is expected to grow with a CAGR of 5.2% from 2024 to 2030.

Q.3. What are the major drivers influencing the growth of the clot management devices market?

Answer: The major drivers for this market are rising prevalence of cardiovascular diseases and ageing population, increasing inclination towards minimally invasive surgeries and on-going advancements in technologies.

Q.4. What are the major segments for clot management devices market?

Answer: The future of the clot management devices market looks promising with opportunities in the diagnostic centers, and hospitals markets.future of the global clot management devices market looks promising with opportunities in the diagnostic center and hospital markets.

Q.5. Who are the key clot management devices market companies?

Answer: Some of the key clot management devices companies are as follows:

• Medtronic
• Boston Scientific Corporation
• iVascular SLU
• Teleflex
• Edwards Lifesciences Corporation
• LeMaitre Vascular
• Vascular Solutions
• Straub Medical
• Cook Medical
• DePuy Synthes

Q.6. Which clot management devices market segment will be the largest in future?

Answer: Lucintel forecasts that neurovascular embolectomy device is expected to witness highest growth over the forecast period because it helps in treating medical conditions like embolism, primarily occuring in brain bolld vessels.

Q.7. In clot management devices market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to increasing prevalence of cardiovascular diseases and improvement in the healthcare infrastructure in the region.

Q.8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the clot management devices market by product (neurovascular embolectomy devices, embolectomy balloon catheters, percutaneous thrombectomy devices,catheter-directed thrombolysis (CDT) devices, and inferior vena cava filters (IVCF)), percutaneous thrombectomy devices type (aspiration thrombectomy devices and percutaneous mechanical thrombectomy devices), end use (diagnostic centers, hospitals, and others), and region. (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?